Macrogenics (MGNX) Non-Current Deferred Revenue (2012 - 2025)
Macrogenics (MGNX) reported Non-Current Deferred Revenue of $55.5 million for Q4 2025, unchanged from $55.5 million a year earlier and down 0.6% from the prior quarter.
Powered by 
Analysis
Macrogenics (MGNX) Non-Current Deferred Revenue (2012 - 2025) Analysis & Trends
Dating back to Q4 2012, Macrogenics' Non-Current Deferred Revenue record includes 50 quarters.
- Non-Current Deferred Revenue has a five-year compound annual growth rate of 51.6% (FY2020 to FY2025).
- By year, Non-Current Deferred Revenue came in at $55.5 million in FY2024 (-6.3%), $59.24 million in FY2023 (-0.4%) and $59.48 million in FY2022.
- Five-year quarterly Non-Current Deferred Revenue spans a low of $5.08 million in Q3 2022 and a high of $64.26 million in Q3 2023.
- Year over year, Non-Current Deferred Revenue gained in two of the last eight quarters, with an average decline of 3.5%.
- The high point for year-over-year Non-Current Deferred Revenue in five years was Q2 2023 (growth of 849.8%); the low point was Q2 2022 (a decline of 54.3%).
- Per Business Quant data, the three quarters before Q4 2025 came in at $55.84 million (Q3 2025), $55.75 million (Q2 2025) and $55.94 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn |
| 10 | Macrogenics | 150.40 Mn | -167.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 55.50 Mn |
| Sep 30, 2025 | 55.84 Mn |
| Jun 30, 2025 | 55.75 Mn |
| Mar 31, 2025 | 55.94 Mn |
| Dec 31, 2024 | 55.50 Mn |
| Sep 30, 2024 | 55.50 Mn |
| Jun 30, 2024 | 55.50 Mn |
| Mar 31, 2024 | 56.18 Mn |
| Dec 31, 2023 | 59.24 Mn |
| Sep 30, 2023 | 64.26 Mn |
| Jun 30, 2023 | 58.54 Mn |
| Mar 31, 2023 | 58.01 Mn |
| Dec 31, 2022 | 59.48 Mn |
| Sep 30, 2022 | 5.08 Mn |
| Jun 30, 2022 | 6.16 Mn |
| Mar 31, 2022 | 6.36 Mn |
| Sep 30, 2021 | 9.58 Mn |
| Jun 30, 2021 | 13.48 Mn |
| Mar 31, 2021 | 7.26 Mn |
| Dec 31, 2020 | 6.93 Mn |
API Access
Macrogenics Non-Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=MGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "MGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=MGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();